Cited by 113Antifungal resistance and susceptibilityNeutropenia and Cancer InfectionsFungal and yeast genetics research

Probable Invasive Aspergillosis without Prespecified Radiologic Findings: Proposal for Inclusion of a New Category of Aspergillosis and Implications for Studying Novel Therapies

Nucci, Marcio, Nouér, Simone Aranha, Grazziutti, Monica, Kumar, Naveen Sanath, Barlogie, Bart, Anaissie, Elias·2010·Clinical Infectious Diseases

Abstract

BACKGROUND: The European Organization for Research and Treatment of Cancer (EORTC) and the Mycosis Study Group (MSG) definition of invasive aspergillosis used in clinical trials lacks sensitivity. We hypothesize that giving lower weight to the prespecified radiologic findings in patients with a positive serum galactomannan index test result will improve the definition's diagnostic sensitivity. METHODS: The medical records of 121 patients with 125 cases of invasive aspergillosis treated at a referral cancer institute from January 2003 through December 2009 were reviewed. Aspergillosis was diagnosed as EORTC-MSG proven or probable (controls, 83) or probable invasive aspergillosis without prespecified radiologic criteria (cases, 42). The latter differed from the former by the inclusion of patients whose pulmonary infiltrates, although well described in invasive aspergillosis, do not fulfill EORTC-MSG invasive aspergillosis requirements. The host, clinical, and mycologic characteristics and survival of cases and controls served as end points. RESULTS: A total of 114 (91%) of 125 patients had multiple myeloma. Patients had a median age was 65 years (range, 26-81 years), and 74 were male. All had received antineoplastic therapy, including stem cell transplantation (58 [46%]). Aspergillosis involved lungs (88 patients), sinuses (9 patients), or both (28 patients). Except for higher median baseline platelet count and shorter duration of neutropenia among cases, there were no statistically significant differences between groups on all predefined end points, including 4-, 6-, and 12-week survival. Eleven of 26 cases were reclassified as controls on the basis of subsequent imaging. CONCLUSIONS: Except for less well-circumscribed consolidations, the host, clinical, radiologic, and mycologic characteristics and outcome of patients with probable invasive aspergillosis but without prespecified radiologic criteria are similar to those with EORTC-MSG invasive aspergillosis. Enrolling such patients in clinical trials of novel therapies will increase the pool of eligible study participants and improve trial speed and efficiency.

Integrity signals

Registry

Crossref · 10.1086/657065

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Clinical and radiologic presentation of IPA in the expanding group of nonneutropenic patients who develop infection is atypical, including cases with tree-in-bud opacities or diffuse ground glass appearance in CT.

    “Nonetheless, clinical and radiologic presentation of IPA in the expanding group of nonneutropenic patients who develop infection is atypical, including cases with tree-in-bud opacities or diffuse ground glass appearance in CT (95).”

    From Aspergillus fumigatus and Aspergillosis in 2019 (2019) · cites this paper as [95]

  • A large proportion of IPA cases still are not detected by existing criteria, especially in nonneutropenic patients who possess atypical clinical and radiographic features of infection.

    “However, a large proportion of IPA cases still are not detected by existing criteria, especially in nonneutropenic patients who possess atypical clinical and radiographic features of infection (95–97).”

    From Aspergillus fumigatus and Aspergillosis in 2019 (2019) · cites this paper as [95]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Nucci, M., Nouér, S. A., Grazziutti, M., Kumar, N. S., Barlogie, B., & Anaissie, E.
Affiliations
  • Hospital Universitário Clementino Fraga Filho (BR)
  • University of Arkansas for Medical Sciences (US)
Corresponding author
Anaissie, Elias
Venue
Clinical Infectious Diseases
Published
2010-12
Volume
51
Issue
11
Pages
1273-1280
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2144686332
Cited by
112
References
33
Citations by year
2026: 3 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 6 · 2021: 6 · 2020: 5 · 2019: 8 · 2018: 5 · 2017: 5 · 2016: 13 · 2015: 8 · 2014: 6 · 2013: 9 · 2012: 20
FWCI
8.68
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
Keywords
invasive aspergillosis, diagnostic sensitivity, serum galactomannan, pulmonary infiltrates, multiple myeloma, stem cell transplantation, antineoplastic therapy, survival, inclusion and exclusion criteria
MeSH terms
Adult, Aged, Aged, 80 and over, Aspergillosis, Aspergillus, Female, Galactose, Humans, Lung, Male, Mannans, Middle Aged, Paranasal Sinuses, Radiography, Retrospective Studies, Survival Analysis, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review